Coumarins as novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer
Bioorganic & Medicinal Chemistry Letters(2010)
Abstract
Compound 4p was identified as a potent selective inhibitor of 17β-HSD3 resulting in the discovery of a novel lead series for further optimization.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined